Autopsy report · NCT00166712
A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression
Cause of deathFutility, also funding or business
“Study stopped due to lack of efficacy \& funding.”
Life of this trial
- Registered 5 months after it had already started.
- Ran for about 5 years before it stopped.
- 40 participants enrolled.
- Results were posted on the registry 4 years 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Northwestern University
- Sponsor type
- University, hospital or other
- Conditions
- Kidney Transplant Failure and Rejection
- Interventions
- Tacrolimus (TAC); Sirolimus; Alemtuzumab; Mycophenolate mofetil (MMF)
- Participants
- 40
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
“Study stopped due to lack of efficacy.” - Dim Light at Night in Patients With Obstructive Sleep Apnea
“The study was stopped due to lack of funding.” - Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
“The study was stopped because of lack of funding.” - Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM
“The study was terminated due to lack of efficacy.” - A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
“The study was early terminated due to lack of efficacy.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.